Search details
1.
Limited value of CA 19-9 in predicting early treatment failure in patients with advanced pancreatic cancer.
Oncology
; 77(2): 140-6, 2009.
Article
in English
| MEDLINE | ID: mdl-19628952
2.
Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.
J Clin Oncol
; 21(7): 1307-12, 2003 Apr 01.
Article
in English
| MEDLINE | ID: mdl-12663719
3.
Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.
J Clin Oncol
; 20(1): 165-72, 2002 Jan 01.
Article
in English
| MEDLINE | ID: mdl-11773166
4.
Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.
Clin Cancer Res
; 8(5): 1051-6, 2002 May.
Article
in English
| MEDLINE | ID: mdl-12006518
5.
UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Anticancer Drugs
; 18(6): 709-12, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17762401
6.
Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer.
Acta Oncol
; 46(2): 208-13, 2007.
Article
in English
| MEDLINE | ID: mdl-17453371
7.
Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.
Cancer Invest
; 20(1): 60-8, 2002.
Article
in English
| MEDLINE | ID: mdl-11853004
8.
Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancer.
Oncology
; 65(3): 211-7, 2003.
Article
in English
| MEDLINE | ID: mdl-14657594
Results
1 -
8
de 8
1
Next >
>>